163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study.

Authors :: Chan, A.T.C.
Lee, H.F.V.
Hong, R-L.
Ahn, M-J.
Chong, W.Q.
Kim, S-B.
Fuang, H.G.
Caguioa, P.B.
Ngamphaiboon, N.
Ho, C.
Abdul Aziz, M.A.S.
Ng, Q.S.
Yen, C.J.
Soparattanapaisarn, N.
Ngan, R.
Kho, S.K.
Wang, L.
Swaby, R.
Saraf, S.
Siu, L.L.
Source :: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1452-S1452. 1p.
Publication Year :: 2021

Subjects :: *NASOPHARYNX cancer
*QUALITY of life
*PEMBROLIZUMAB
*CANCER chemotherapy
*METASTASIS

Full Text Access

Tools